Hutchmed's net profit plunged 63 percent

Hutchmed (China) (0013) recorded a net profit of US$37.7 million (HK$294.06 million) in 2024, down nearly 63 percent from a year prior, blaming the higher gains from associates in 2023.

Revenue last year amounted to US$630 million, down 24.8 percent over 2023.

However, consolidated revenue from oncology products recorded US$271.5 million, surging 65 percent.

STAFF REPORTER